Valerio Therapeutics (XPAR:ALVIO) Total Assets : €35.27 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Valerio Therapeutics Total Assets?

Valerio Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was €35.27 Mil.

During the past 12 months, Valerio Therapeutics's average Total Assets Growth Rate was -0.20% per year. During the past 3 years, the average Total Assets Growth Rate was -3.80% per year. During the past 5 years, the average Total Assets Growth Rate was -8.90% per year. During the past 10 years, the average Total Assets Growth Rate was -2.90% per year.

During the past 13 years, Valerio Therapeutics's highest 3-Year average Total Assets Growth Rate was 159.60%. The lowest was -30.70%. And the median was -3.75%.

Total Assets is connected with ROA %. Valerio Therapeutics's annualized ROA % for the quarter that ended in Dec. 2023 was -43.89%. Total Assets is also linked to Revenue through Asset Turnover. Valerio Therapeutics's Asset Turnover for the quarter that ended in Dec. 2023 was 0.05.

Valerio Therapeutics Total Assets Historical Data

The historical data trend for Valerio Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valerio Therapeutics Total Assets Chart

Valerio Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

37.63

46.51

53.06

43.09

35.27

Valerio Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Assets	Get a 7-Day Free Trial															53.06	56.70	43.09	44.02	35.27

Valerio Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Valerio Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	14.805	+	20.469
	=	35.27

Valerio Therapeutics's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	14.805	+	20.469
	=	35.27

Valerio Therapeutics (XPAR:ALVIO) Total Assets Explanation

Total Assets is connected with ROA %.

Valerio Therapeutics's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-17.4	/	( (44.02	+	35.274)	/ 2 )
	=	-17.4	/	39.647
	=	-43.89 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Valerio Therapeutics's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	1.8	/	( (44.02	+	35.274)	/ 2 )
=	1.8	/	39.647
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Valerio Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Valerio Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Valerio Therapeutics (XPAR:ALVIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valerio Therapeutics (XPAR:ALVIO) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

C4X:Germany

Address

49 Boulevard du General, Martial Valin, Paris, FRA, 75015

Website

https://www.valeriotx.com

Valerio Therapeutics is a clinical-stage biotechnology company designing and developing novel oncology drugs targeting tumor DNA repair functions. Its therapeutic strategy focuses on fighting tumor resistance to treatments, which poses ever-greater therapeutic challenges, especially in aggressive or rare cancers. its approach is based upon unique mechanisms of action on DNA Damage Response. The company focuses on bringing first-in-class and disruptive compounds from preclinical research to proof-of-concept in man in cancer indications with high unmet needs.

Valerio Therapeutics (XPAR:ALVIO) Headlines

No Headlines